Cizzle Biotechnology Holdings Plc
CIZ.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £365 | £144 | £478 | £875 |
| Short-Term Investments | £22 | £1,413 | £0 | £0 |
| Receivables | £103 | £136 | £227 | £80 |
| Inventory | £2 | -£1,549 | -£0 | -£0 |
| Other Curr. Assets | £0 | £1,549 | £0 | £0 |
| Total Curr. Assets | £492 | £1,693 | £705 | £955 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £2,080 | £200 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £0 | £0 | £2,080 | £200 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £492 | £1,693 | £2,785 | £1,155 |
| Liabilities | – | – | – | – |
| Payables | £13 | £92 | £41 | £111 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £7 | £7 | £8 | £43 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £390 | £87 | £96 | £64 |
| Total Curr. Liab. | £410 | £186 | £145 | £218 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £41 | £111 |
| Other Liabilities | £0 | £0 | -£41 | -£111 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £410 | £186 | £145 | £218 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £40 | £3,504 | £3,502 | £3,493 |
| Retained Earnings | -£10,036 | -£7,870 | -£6,153 | -£5,517 |
| AOCI | £0 | -£29,462 | -£29,626 | -£29,605 |
| Other Equity | £10,078 | £35,335 | £34,917 | £32,566 |
| Total Equity | £82 | £1,507 | £2,640 | £937 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £492 | £1,693 | £2,785 | £1,155 |
| Net Debt | -£365 | -£144 | -£478 | -£875 |